The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca (Inst); BeiGene (Inst); Dizal Pharma (Inst); Gilead Sciences; Janssen-Cilag (Inst); Loxo/Lilly; Menarini (Inst); Novartis; Roche/Genentech (Inst); TG Therapeutics
Consulting or Advisory Role - AstraZeneca; BeiGene (Inst); Dizal Pharma (Inst); Gilead Sciences; Janssen-Cilag; Kite, a Gilead company (Inst); Loxo/Lilly; Menarini (Inst); Roche/Genentech (Inst)
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche
Extended follow-up results beyond 2.5 years from the pivotal NHL-1 EPCORE trial: Subcutaneous epcoritamab monotherapy in patients with relapsed/refractory large B-cell lymphoma (R/R LBCL).
 
Yasmin Karimi
Consulting or Advisory Role - Abbvie; ADC Therapeutics
Research Funding - Abbvie; AstraZeneca; Loxo/Lilly; Merck; Roche/Genentech; Xencor
Travel, Accommodations, Expenses - Roche/Genentech
 
Catherine Thieblemont
Honoraria - Abbvie; Bayer; Celgene; Gilead Sciences; Incyte; Janssen; Novartis; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Abbvie; Janssen-Cilag; Kite/Gilead; Novartis; Roche
 
Hervé Ghesquieres
Honoraria - Abbvie; Gilead Sciences; Roche
Consulting or Advisory Role - Gilead Sciences; Roche
Travel, Accommodations, Expenses - Abbvie; Pierre Fabre
 
Chan Y Cheah
No Relationships to Disclose
 
Michael Roost Clausen
Consulting or Advisory Role - Abbvie; AstraZeneca; Genmab; Gilead Sciences; Incyte; Janssen
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Genmab; Janssen; Roche
 
David Cunningham
Stock and Other Ownership Interests - OVIBIO
Consulting or Advisory Role - OVIBIO
Research Funding - 4SC (Inst); Bayer (Inst); Clovis Oncology (Inst); Leap Oncology (Inst); Lilly (Inst); MedImmune (Inst); Roche (Inst)
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; BeiGene; Lilly
Research Funding - AstraZeneca; BeiGene; Janssen-Cilag; Lilly; Morphosys; Roche; Takeda
 
Kim M. Linton
Honoraria - Genmab
Consulting or Advisory Role - Abbvie; BeiGene; Bristol-Myers Squibb/Celgene; Kite/Gilead; Roche
Speakers' Bureau - Genmab; Hartley Taylor Medical
Research Funding - Genmab (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BeiGene; Hartley Taylor Medical; Roche
 
Martin Hutchings
Consulting or Advisory Role - Abbvie; Genmab; Janssen; Roche; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Genmab (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
 
Tycel Jovelle Phillips
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; ADC Therapeutics; AstraZeneca; Bayer; BeiGene; BMS GmbH & Co. KG; Epizyme; Genentech; Genmab; Gilead Sciences; Incyte; Janssen; Kite/Gilead; Lilly; Merck; Pharmacyclics
Research Funding - Abbvie; Genentech
 
Umar Farooq
Honoraria - Caribou Biosciences; Kite, a Gilead company; Morphosys
Research Funding - Checkmate Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Won Seog Kim
Research Funding - BeiGene; Boryung; Dong-A Pharm; F. Hoffmann LaRoche; Kyowa Kirin; Sanofi
 
Minh H Dinh
Employment - Abbvie
 
Jagannath Ghosh
Employment - Genmab
 
Rajash Pallai
Employment - Genmab; HUTCHMED
 
Monica Wielgos-Bonvallet
Employment - Genmab
 
Christian Eskelund
Employment - Genmab
 
Pieternella Lugtenburg
Consulting or Advisory Role - Abbvie; Genmab; Incyte; Regeneron; Roche/Genentech; Y-mAbs Therapeutics
Speakers' Bureau - Abbvie; Lilly
Research Funding - Takeda (Inst)
Travel, Accommodations, Expenses - Celgene
 
Julie Vose
Honoraria - Abbvie; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; Genmab; Lilly; MEI Pharma; Ono Pharmaceutical
Consulting or Advisory Role - Foresight Diagnostics
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Epizyme; Genmab; Kite, a Gilead company (Inst); Loxo; Novartis (Inst); Seagen (Inst)